Lysergic acid diethylamide induces increased signalling entropy in rats' prefrontal cortex.
Aurora SavinoCharles D NicholsPublished in: Journal of neurochemistry (2021)
Psychedelic drugs are gaining attention from the scientific community as potential new compounds for the treatment of psychiatric diseases such as mood and substance use disorders. The 5-HT2A receptor has been identified as the main molecular target, and early studies pointed to an effect on the expression of neuroplasticity genes. Analysing RNA-seq data from the prefrontal cortex of rats chronically treated with lysergic acid diethylamide (LSD), we describe the psychedelic-induced rewiring of gene co-expression networks, which become less centralised but more complex, with an overall increase in signalling entropy typical of highly plastic systems. Intriguingly, signalling entropy mirrors, at the molecular level, the increased brain entropy reported through neuroimaging studies in human, suggesting the underlying mechanisms of higher-order phenomena. Moreover, from the analysis of network topology, we identify potential transcriptional regulators and propose the involvement of different cell types in psychedelics' activity.
Keyphrases
- prefrontal cortex
- rna seq
- single cell
- poor prognosis
- mental health
- genome wide
- case control
- transcription factor
- healthcare
- binding protein
- bipolar disorder
- gene expression
- human health
- high glucose
- single molecule
- genome wide identification
- working memory
- copy number
- drug induced
- white matter
- oxidative stress
- big data
- dna methylation
- heat shock
- risk assessment
- induced pluripotent stem cells
- depressive symptoms
- stem cells
- smoking cessation
- artificial intelligence
- sleep quality
- network analysis
- multiple sclerosis
- data analysis
- heat stress